PCC | Jotup

Laekna Announces Two Poster Presentations on Internally Discovered Drug Candidates at AACR 2024

Retrieved on:

월요일, 4월 8, 2024

"After advancing LAE102, our internally discovered antibody against ActRIIA, into IND stage, Laekna continues to strengthen our internal discovery efforts, with new drug candidates emerging", said Dr. Justin Gu, Chief Scientific Officer of Laekna.

Key Points:

"After advancing LAE102, our internally discovered antibody against ActRIIA, into IND stage, Laekna continues to strengthen our internal discovery efforts, with new drug candidates emerging", said Dr. Justin Gu, Chief Scientific Officer of Laekna.
Laekna will continue our internal effort of discovery novel drug candidates to provide more options for patients."
The company has internally discovered 14 drug candidates, among which seven have been optimized and advanced to PCC (pre-clinical candidate) stage.
The Annual Meeting of AACR is set for April 05 to 10, 2024 at the San Diego Convention Center, California, USA.

PyroGenesis Announces Accelerated Construction of Fumed Silica Reactor Project with Arrival of All Major Equipment

Retrieved on:

화요일, 3월 12, 2024

Hydrogen, Adhesive, Silicon dioxide, Fumed silica, Agriculture, Safety, GHG, EBIDTA, Health, Ventilation, FRA, 0 A.D. (video game), HPQ, FSR, TPY, Pollution, Carbon, Silicon, TSX, Siloxane, CO2, Silicon tetrachloride, Confidentiality, News, AN, Use, Oxygen, Greenhouse, PCC, Cement

The Fumed Silica Reactor (FSR) technology project is being conducted in conjunction with HPQ Silica Polvere Inc. (“HPQ Polvere”), a wholly owned subsidiary of HPQ.

Key Points:

The Fumed Silica Reactor (FSR) technology project is being conducted in conjunction with HPQ Silica Polvere Inc. (“HPQ Polvere”), a wholly owned subsidiary of HPQ.
With all major equipment now on site, the construction phase of the 50 tonnes per year (TPY) FSR pilot plant is accelerating.
The FSR converts quartz into fumed silica (also known as pyrogenic silica) in a single and eco-friendly step while eliminating the use of harmful chemicals generated by conventional methods.
Fumed silica sales accounted for almost 23% of the global specialty silica market at the end of 2021.

Howmet Aerospace Announces Leadership Appointment

Retrieved on:

월요일, 3월 25, 2024

Effective April 8, 2024, Johan (John) Wall will join Howmet Aerospace (NYSE:HWM) as President, Engineered Structures.

Key Points:

Effective April 8, 2024, Johan (John) Wall will join Howmet Aerospace (NYSE:HWM) as President, Engineered Structures.
In this role, John will have responsibility for all Engineered Structures employees and locations globally.
John will be based in Cleveland, OH, and will report directly to John Plant, Executive Chairman and Chief Executive Officer.
During his 17-year tenure with PCC, John held roles of progressive accountability including Regional Vice President of PCC Aerostructures, General Manager – Aerospace Dynamics International, General Manager – Centra Industries, Director of Sales – Centra Industries, and Director of Quality – Centra Industries.

Precision Coating Expands Commercial Team, Naming Charlie Fields as Vice President of Market Development

Retrieved on:

수요일, 3월 13, 2024

Chemicals, Plastics, Other Manufacturing, Manufacturing, Growth, Original equipment manufacturer, Victrex, Knowledge, Market development, Multimedia, PPG, Medtech, PCC, 3D printing

Precision Coating Company, LLC announced today that Charlie Fields has joined the company as Vice President of Market Development.

Key Points:

Precision Coating Company, LLC announced today that Charlie Fields has joined the company as Vice President of Market Development.
Based in Hudson, MA, Precision Coating serves global medical and technical companies offering value-added surface coatings and treatments.
His extensive experience with coating formulations and application technologies will enable Charlie to positively impact all aspects of market development and expansion and commercial growth at PCC.
In addition to business and market development roles, Fields spent many years in operations roles and has experience in R&D, applications development, and manufacturing over his career.

Switchboard Health and CareJourney Partner to Support the Transition to Value-Based Specialty Care

Retrieved on:

수요일, 4월 3, 2024

Partnership, Health, Patient, Software, Organization, Ecosystem, PCC, Nursing

BOISE, Idaho, April 3, 2024 /PRNewswire-PRWeb/ -- Switchboard Health, creator of a high-value specialty care network and software platform, and CareJourney, the market leader in provider cost and quality data, have partnered to deliver an integrated set of offerings to support value-based care providers and health plans. These offerings are improving specialty care navigation and supporting the successful transition to value-based specialty care.

Key Points:

Switchboard Health, creator of a high-value specialty care network and software platform, and CareJourney, the market leader in provider cost and quality data, have partnered to deliver an integrated set of offerings to support value-based care providers and health plans.
BOISE, Idaho, April 3, 2024 /PRNewswire-PRWeb/ -- Switchboard Health , creator of a high-value specialty care network and software platform, and CareJourney , the market leader in provider cost and quality data, have partnered to deliver an integrated set of offerings to support value-based care providers and health plans.
These offerings are improving specialty care navigation and supporting the successful transition to value-based specialty care.
To learn more about how CareJourney and Switchboard Health can enable your value-based specialty care roadmap, reach us at https://www.switchboardhealth.com/providers#1

Komen Closes Gaps with High-Quality Breast Support Every Step of the Way

Retrieved on:

수요일, 3월 27, 2024

Diamond, Diagnosis, Disease, Caregiver, Community health, Patient, Cancer, Woman, Breast cancer, Genetic counseling, Courage, PCC, Birth control

DALLAS, March 27, 2024 /PRNewswire/ -- For many, the path to high-quality breast health care is complex and challenging even in the best circumstances. People from underresourced communities, especially women of color, encounter even more barriers to care as they make their way through a fragmented health care system.

Key Points:

People from underresourced communities, especially women of color, encounter even more barriers to care as they make their way through a fragmented health care system.
Susan G. Komen® is committed to ensuring all people receive the support and high-quality care they need at every step of their breast health journey.
Here are the top 5 ways Komen's PCC navigators provide support throughout your breast health care experience:
We provide information and educational resources about breast cancer screening and treatment options.
Dealing with a breast cancer diagnosis is tough, as is waiting on test results or finding the courage to support a loved one through it all.

Hydrochloric Acid Market Size to Grow by USD 978.77 million, 5.72% YOY market growth in 2023-2024, Technavio

Retrieved on:

목요일, 3월 14, 2024

The food segment, valued at USD 689.47 million in 2018, drives significant growth in the hydrochloric acid market.

Key Points:

The food segment, valued at USD 689.47 million in 2018, drives significant growth in the hydrochloric acid market.
The report provides actionable insights and estimates the contribution of all regions to the growth of the global hydrochloric acid market.
Expansion of hydrochloric acid facilities, like SGL Carbon's unit delivery to Travancore-Cochin Chemicals Ltd., drives market growth, enabling companies to enhance their market presence and offer a wider product range, boosting the global hydrochloric acid market.
Substitutes like emerald-safe acid, phosphoric acid, sodium bisulfate, and trisodium phosphate pose challenges to hydrochloric acid market growth.

New Real-World Data Further Support the Use of Veklury® (Remdesivir) for People Hospitalized With COVID-19

Retrieved on:

화요일, 3월 5, 2024

Health, Infectious Diseases, Hospitals, COVID-19, Clinical Trials, Pharmaceutical, Biotechnology, Omicron, PCC, Dexamethasone, Senior, Patient, Mortality, Immunodeficiency, Gilead Sciences, CROI, MD, Risk, Pharmaceutical industry

One study showed Veklury® (remdesivir) was associated with a reduced risk of certain long-COVID symptoms in people who were hospitalized for COVID-19.

Key Points:

One study showed Veklury® (remdesivir) was associated with a reduced risk of certain long-COVID symptoms in people who were hospitalized for COVID-19.
“As we enter the fourth year of COVID-19, Veklury remains the antiviral standard of care for people hospitalized for COVID-19.
Results from this analysis build on existing evidence that support the importance of treating COVID-19 early in the disease course with an antiviral.
Patients on invasive mechanical ventilation/ECMO at baseline had a 19% (p=0.0182) reduced risk for mortality at Day 28.

Podiatry Content Connection Launches Patient Pro-Connect™

Retrieved on:

수요일, 2월 28, 2024

PCC, Marketing, Insurance, Patient, Surgeon, Podiatry

METUCHEN, N.J., Feb. 28, 2024 /PRNewswire/ -- Podiatry Content Connection (PCC), an expert in digital marketing solutions for the podiatry industry, continues to expand and enhance its service offerings in 2024.

Key Points:

METUCHEN, N.J., Feb. 28, 2024 /PRNewswire/ -- Podiatry Content Connection (PCC), an expert in digital marketing solutions for the podiatry industry, continues to expand and enhance its service offerings in 2024.
"Many patients don't realize the podiatrists' scope of work or even know that they are surgeons," says Jeffrey Hartman, CEO of Podiatry Content Connection.
With a name like Podiatry Content Connection it's easy to see why PCC has developed this program that builds lasting relationships between podiatrists and their patients.
For more information about Podiatry Content Connection or "Patient Pro-Connect™", contact PCC at 718-475-9449 visit PodiatryCC.com, or follow on Facebook .

Podiatrists: 2 New Services Attract More Patients & Connect with Existing Ones

Retrieved on:

월요일, 2월 19, 2024

AI, PCC, Podiatry, Practice, Patient, Hotel Indigo

"We are very excited to add these programs to our suite of services that attract new patients, and create better connections with existing patients, for podiatrists and chiropodists worldwide," says Jeffrey Hartman, founder and CEO of Podiatry Content Connection.

Key Points:

"We are very excited to add these programs to our suite of services that attract new patients, and create better connections with existing patients, for podiatrists and chiropodists worldwide," says Jeffrey Hartman, founder and CEO of Podiatry Content Connection.
Podiatry Content Connection will be introducing Practice Builder™ and Patient Pro-Connect™ at the PRESENT TREASURE HUNT conference at the Hotel Indigo in Los Angeles, CA, Feb. 24-25, 2024.
Using AI technology, Practice Builder™ brings in new patients and increases online visibility with SEO-enhanced content and 70+ optimized online directory listings.
Patient Pro-Connect™ drives additional appointments with existing patients, through recurrent email campaigns that connect, educate, and promote cash-pay services, like wart removal and laser treatments.